Correlation Between Sam-A Pharm and Daihan Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sam-A Pharm and Daihan Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sam-A Pharm and Daihan Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sam A Pharm Co and Daihan Pharmaceutical CoLtd, you can compare the effects of market volatilities on Sam-A Pharm and Daihan Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sam-A Pharm with a short position of Daihan Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sam-A Pharm and Daihan Pharmaceutical.

Diversification Opportunities for Sam-A Pharm and Daihan Pharmaceutical

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sam-A and Daihan is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Sam A Pharm Co and Daihan Pharmaceutical CoLtd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daihan Pharmaceutical and Sam-A Pharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sam A Pharm Co are associated (or correlated) with Daihan Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daihan Pharmaceutical has no effect on the direction of Sam-A Pharm i.e., Sam-A Pharm and Daihan Pharmaceutical go up and down completely randomly.

Pair Corralation between Sam-A Pharm and Daihan Pharmaceutical

Assuming the 90 days trading horizon Sam A Pharm Co is expected to generate 3.97 times more return on investment than Daihan Pharmaceutical. However, Sam-A Pharm is 3.97 times more volatile than Daihan Pharmaceutical CoLtd. It trades about 0.02 of its potential returns per unit of risk. Daihan Pharmaceutical CoLtd is currently generating about -0.01 per unit of risk. If you would invest  1,615,168  in Sam A Pharm Co on September 12, 2024 and sell it today you would earn a total of  44,832  from holding Sam A Pharm Co or generate 2.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sam A Pharm Co  vs.  Daihan Pharmaceutical CoLtd

 Performance 
       Timeline  
Sam A Pharm 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sam A Pharm Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Daihan Pharmaceutical 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Daihan Pharmaceutical CoLtd are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Daihan Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Sam-A Pharm and Daihan Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sam-A Pharm and Daihan Pharmaceutical

The main advantage of trading using opposite Sam-A Pharm and Daihan Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sam-A Pharm position performs unexpectedly, Daihan Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daihan Pharmaceutical will offset losses from the drop in Daihan Pharmaceutical's long position.
The idea behind Sam A Pharm Co and Daihan Pharmaceutical CoLtd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance